Capitalize on AI’s Drug Discovery Disruption: Benchmark NVIDIA, Schrödinger, Recursion, Insilico Medicine and Exscientia to Secure R&D ROI and Competitive Advantage Through 2030
Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "AI in Drug Discovery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for AI in Drug Discovery was estimated at US$2.4 Billion in 2025 and is projected to reach US$14.3 Billion by 2032, growing at a CAGR of 28.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Report Scope
The report analyzes the AI in Drug Discovery market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
Key Insights:
Why You Should Buy This Report:
Key Questions Answered:
Report Features:
Some of the companies featured in this AI in Drug Discovery market report include:
Domain Expert Insights
This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 14,839 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.
Key Attributes:
For more information about this report visit https://www.researchandmarkets.com/r/5ai4vw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.